Abagovomab Uses, Dosage, Side Effects and more
Abagovomab is under investigation in clinical trial NCT00418574 (Efficacy Multicentre Trial of Immunotherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients).
| Attribute | Details |
|---|---|
| Trade Name | Abagovomab |
| Generic | Abagovomab |
| Abagovomab Other Names | Abagovomab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
